Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Annovis Bio, Inc. (ANVS)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Operating expenses:          
Research and development  8.37.81.65.34.02.12.91.4
General and administrative  1.52.21.62.41.93.13.01.5
    Total operating expenses  9.810.03.27.76.05.35.92.9
    Operating loss  -9.8-10.0-3.2-7.7-6.0-5.3-5.9-2.9
   
Other income:          
Interest income, net  0.20.20.10.10.00.00.00.0
    Total other income  0.20.20.10.10.00.00.00.0
    Loss before income taxes  -9.5-9.7-25.3 -5.9-5.2-14.5 
    Net loss  -9.5-9.7-3.1-7.6-5.9-5.2-5.9-2.8
   
Basic loss per common share  ($1.07)($1.19)($0.38)($0.93)($0.73)($0.64)($0.75)($0.35)
Diluted loss per common share  ($1.07)($1.19)($0.38)($0.93)($0.73)($0.64)($0.75)($0.35)
   
Weighted average number of common shares outstanding, basic  9.08.28.28.28.28.27.68.1
Weighted average number of common shares outstanding, diluted  9.08.28.28.28.28.27.68.1

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy